Signal transduction in environmental neurotoxicity

Annual Review of Pharmacology and Toxicology

Volumn 38, Issue , 1998, Pages 21-45

  Costa, L G ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b IRCCS   (Italy)

Author keywords

Calcium; Cell signaling; Ethanol; Lead; Protein kinase C

Indexed keywords

ALCOHOL; LEAD; PHOSPHOLIPID; POLYCHLORINATED BIPHENYL DERIVATIVE; PROTEIN KINASE C; TOXIC SUBSTANCE; TRIMETHYLTIN;

CYTOTOXICITY; ENVIRONMENT; GLIA CELL; GRANULE CELL; HUMAN; LEAD POISONING; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PURKINJE CELL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031777717     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.38.1.21     Document Type: Review

References (183)

1. National Research Council. 1992. Environmental Neurotoxicology. Washington, DC: Natl. Acad. Press
2. Tilson HA, MacPhail RC, Crofton KM. 1995. Defining neurotoxicity in a decision making context. NeuroToxicology 16:363-76
3. Office of Technology Assessment. 1990. Neurotoxicity: Identifying and Controlling Poisons of the Nervous System. Washington, DC: US Gov. Print. Off.
4. Aldridge WN. 1980. The need to understand mechanisms. In The Scientific Basis of Toxicity Assessment, ed. H Witschi, pp. 305-19. Amsterdam: Elsevier
5. Castoldi AF, Coccini T, Rossi A, Nicotera P, Costa LG, Tan XX, Manzo L. 1994. Biomarkers in environmental medicine: alterations of cell signaling as early indicators of neurotoxicity. Funct. Neurol. 9:101-9
6. Costa LG. 1996. Biomarkers research in neurotoxicology: the role of mechanistic studies in bridging the gap between the laboratory and epidemiological investigations. Environ. Health Persp. 104 (Suppl. 1):55-67
7. Costa LG. 1998. Neurotoxicity testing. Environ. Health Persp. In press
8. Fowler CJ, Cowburn RF, O'Neill C. 1992. Brain signal transduction disturbances in neurodegenerative disorders. Cell. Signal. 4:1-9
9. Jope RS. 1996. Cholinergic muscarinic receptor signaling by the phosphoinositide signal transduction system in Alzheimer's disease. Alzheimer's Dis. Rev. 1:2-14
10. Choi DW. 1992. Excitotoxic cell death. J. Neurobiol. 23:1261-76
11. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD. 1993. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262:695-700
12. Johnson EM, Deckweth TL. 1993. Molecular mechanisms of developmental neuronal death. Annu. Rev. Neurosci. 16:31-46
13. Margolis RL, Chuang D-M, Post RM. 1994. Programmed cell death: implications for neuropsychiatric disorders. Biol. Psychiatry 35:946-56
14. Henderson CE. 1996. Programmed cell death in the developing nervous system. Neuron 17:579-85
15. Nicotera P, Ankarcrona M, Bonfoco E, Orrenius S, Lipton SA. 1997. Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neurol. 72:95-101
16. Chalmers-Redman RME, Fraser AD, Ju WYH, Wadia J, Tatton NA, Tatton WG. 1997. Mechanisms of nerve cell death: apoptosis or necrosis after cerebral ischaemia. In Neuroprotective Agents and Cerebral Ischaemia, pp. 1-25. San Diego: Academic
17. Costa LG. 1994. Cell signaling and neurotoxic events. In Principles of Neurotoxicology, ed. LW Chang, pp. 475-93. New York: Dekker
18. Costa LG. 1994. Second messenger systems in developmental neurotoxicity. In Developmental Neurotoxicology, ed. GJ Harry, pp. 77-101. Boca Raton, FL: CRC
19. Costa LG. 1997. Role of cell signaling in neurotoxicity. In Comprehensive Toxicology. Vol. 11. Nervous System and Behavioral Toxicology, ed. HE Lowndes, KR Reuhl, pp. 99-113. New York: Elsevier
20. Simon MI, Strathmann MP, Gautam N. 1991. Diversity of G proteins in signal transduction. Science 252:802-8
21. Fisher SK, Heacock AM, Agranoff BW. 1992. Inositol lipids and signal transduction in the nervous system: an update. J. Neurochem. 58:18-38
22. Exton JH. 1996. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters and other agonists linked to G proteins. Annu. Rev. Pharmacol. Toxicol. 36:481-509
23. Liscovitch M. 1996. Phospholipase D: role in signal transduction and membrane traffic. J. Lipid Med. Cell. Signal. 14:215-21
24. English D. 1996. Phosphatidic acid: a lipid messenger involved in intracellular and extracellular signaling. Cell. Signal. 8:341-47
25. Nishizuka Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:489-96
26. Liu J-P. 1996. Protein kinase C and its substrates. Mol. Cell. Endocrinol. 116: 1-29
27. Khan WA, Blobe GC, Hannun YA. 1995. Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cell. Signal. 3:171-84
28. Bonventre JV. 1996. Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity. J. Lipid Med. Cell. Signal. 14:15-23
29. Krebs EG. 1989. Role of cyclic AMP-dependent protein kinase in signal transduction. JAMA 262:1815-18
30. Malarkey K, Belham CM, Paul A, Graham A, McLees A, et al. 1995. The regulation of tyrosine kinase signaling pathways by growth factor and G-protein-coupled receptors. Biochem. J. 309:361-75
31. Bhat MR. 1995. Signal transduction mechanisms in glial cells. Dev. Neurosci. 17:267-84
32. Ferrell JE. 1996. MAP kinases in mitogenesis and development. Curr. Top. Dev. Biol. 33:1-60
33. Zhang J, Snyder SH. 1995. Nitric oxide in the nervous system. Annu. Rev. Pharmacol. Toxicol. 35:213-33
34. Wang X, Robinson PJ. 1997. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68:443-56
35. Edwards DR. 1994. Cell signaling and the control of gene transcription. Trends Pharmacol. Sci. 15:239-44
36. Sheng M, Greenberg ME. 1990. The regulation of c-fos and other intermediate early genes in the nervous system. Neuron 4:477-85
37. Horvath CM, Darnell JE. 1997. The state of the STAT: recent developments in the study of signal transduction to the nucleus. Curr. Opin. Cell Biol. 9:233-39
38. Thanos D, Maniatis T. 1995. NF-κB: a lesson in family values. Cell 80:529-32
39. Nicotera P, Bellomo G, Orrenius S. 1992. Calcium-mediated mechanisms in chemically-induced cell death. Annu. Rev. Pharmacol. Toxicol. 32:449-70
40. Harman AW, Maxwell MJ. 1995. An evaluation of the role of calcium in cell injury. Annu. Rev. Pharmacol. Toxicol. 35:129-44
41. Rubbo H, Darley-Usmar V, Freeman BA. 1996. Nitric oxide regulation of tissue free radical injury. Chem. Res. Toxicol. 9:809-20
42. Varner PD, Beckman JS. 1995. Nitric oxide toxicity in neuronal injury and degeneration. In Nitric Oxide in the Nervous System, pp. 191-206. San Diego: Academic
43. Dawson VL, Dawson TM. 1996. Nitric oxide actions in neurochemistry. Neurochem. Int. 29:97-110
44. Costa LG. 1990. The phosphoinositide/protein kinase C system as a target for neurotoxicity. Pharmacol. Res. 22:393-408
45. Costa LG. 1994. Signal transduction mechanisms in developmental neurotoxicity: the phosphoinositide pathway. NeuroToxicology 15:19-28
46. Nriagu JO. 1996. A history of global metal pollution. Science 272:223-24
47. Goldstein GW. 1992. Neurologic concepts of lead poisoning in children. Pediatr. Ann. 21:384-88
48. Winneke G, Lilienthal H, Kramer U. 1996. The neurobehavioral toxicology and teratology of lead. Arch. Toxicol. Suppl. 18:57-70
49. Bressler JP, Goldstein GW. 1991. Mechanisms of lead neurotoxicity. Biochem. Pharmacol. 41:479-84
50. Silbergeld EK. 1992. Mechanisms of lead neurotoxicity, or looking beyond the lamppost. FASEB J. 6:3201-6
51. Pounds JG. 1984. Effect of lead intoxication on calcium homeostasis and calcium-mediated cell function: a review. NeuroToxicology 5:295-332
52. Audesirk G. 1985. Effects of lead exposure on the physiology of neurons. Prog. Neurobiol. 24:199-231
53. Simons TJB. 1993. Lead-calcium interactions in cellular lead toxicity. NeuroToxicology 14:77-86
54. 2+ in calmodulin. Arch. Toxicol. 54:61-70
55. Goldstein GW. 1993. Evidence that lead acts as a calcium substitute in second messenger metabolism. NeuroToxicology 14:97-102
56. Kern M, Audesirk G. 1995. Inorganic lead may inhibit neunte development in cultured rat hippocampal neurons through hyperphosphorylation. Toxicol. Appl. Pharmacol. 134:111-23
57. Markovac J, Goldstein GW. 1988. Lead activates protein kinase C in immature rat microvessels. Toxicol. Appl. Pharmacol. 96:14-23
58. Markovac J, Goldstein GW. 1988. Picomolar concentrations of lead stimulate brain protein kinase C. Nature 334:71-73
59. Laterra J, Bressler JP, Indurti RR, Belloni-Olivi L, Goldstein GW. 1992. Inhibition of astroglia-induced endothelial differentiation by inorganic lead: a role for protein kinase C. Proc. Natl. Acad. Sci. USA 89:10748-52
60. Long GJ, Rosen JF, Schanne FAX. 1994. Lead activation of protein kinase C from rat brain. J. Biol. Chem. 269:834-37
61. Murakami K, Feng G, Chen SG. 1993. Inhibition of brain protein kinase C subtypes by lead. J. Pharmacol. Exp. Ther. 264:757-61
62. Rajanna B, Chetty CS, Rajanna S, Hall E, Fail S, Yallapragada PR. 1995. Modulation of protein kinase C by heavy metals. Toxicol. Lett. 81:197-203
63. 2+ both activates and inhibits protein kinase C purified from rat brain and in neuronal cell culture. Soc. Neurosci. Abstr. 22:371
64. 2+ and protein kinase C and its role in norepinephrine release from bovine adrenal chromaffin cells. J. Neurochem. 64:2667-73
65. 3H-PDBu binding to hippocampal membrane-bound PKC in lead-exposed rat. Toxicoltigist 14:143 (Abstr.)
66. Reinholz MM, Bertics PJ, Miletic V. 1997. Chronic exposure to inorganic lead modifies protein kinase C activity and the distribution of some of its isozymes in the developing hippocampus. Fund. Appl. Toxicol. 36:104 (Abstr.)
67. Bressler JP, Belloni-Olivi L, Forman S, Goldstein GW. 1996. Distinct mechanisms of neurotransmitter release from PC12 cells exposed to lead. J. Neurosci. Res. 46:678-85
68. Vainio H. 1997. Lead and cancer -association or causation. Scand. J. Work Environ. Health 23:1-3
69. World Health Organization. 1995. Inorganic lead. Environ. Health Criteria 165. Geneva: WHO
70. US Environmental Protection Agency, Office of Health and Environmental Assessment. 1989. Evaluation of potential carcinogenicity of lead and lead compounds [booklet]. Washington, DC: EPA
71. Anttila A, Heikkila P, Nykyri E, Kuappinen T, Pukkala E, et al. 1996. Risk of nervous system cancer among workers exposed to lead. J. Occup. Environ. Med. 38:131-36
72. Hartwig A. 1994. Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review. Environ. Health Perspect. 102(Suppl. 3):45-50
73. Couldwell WT, Antel JP, Yong VW. 1992. Protein kinase C activity correlates with the growth rate of malignant gliomas. Part II. Effects of glioma mitogens and modulators of protein kinase C. Neurosurgery 31:717-24
74. Baltuch GH, Yong VW. 1996. Signal transduction for proliferation of glioma cells in vitro occurs predominantly through protein kinase C-mediated pathway. Brain Res. 710:143-49
75. Naarala J, Loikkanen J, Ruotsalainen M, Savolainen K. 1995. Lead amplifies glutamate-induced oxidative stress. Free Radic. Biol. Med. 19:689-93
76. Naarala J, Loikkanen J, Savolainen K. 1996. The combination of lead with a protein kinase C inhibitor causes oxidative stress in human neuroblastomacells. Neurosci. Res. Commun. 19:135-43
77. Audesirk G. 1993. Electrophysiology of lead intoxication: effects on voltage-sensitive ion channels. NeuroToxicology 14:137-48
78. Busselberg D. 1995. Calcium channels as target sites of heavy metals. Toxicol. Lett. 82-83:255-61
79. ++) promotes apoptosis in newborn rat cerebellar neurons: pathological implications. J. Pharmacol. Exp. Ther. 279:435-42
80. Vig PJS, Pentyala SN, Chetty CS, Rajanna B, Desaiah D. 1994. Lead alters inositol polyphosphate receptor activities: protection by ATP. Pharmacol. Toxicol. 75:17-22
81. Singh AK. 1995. Age-dependent neurotoxicity in rats chronically exposed to low levels of lead: calcium homeostasis in central neurons. NeuroToxicology 14:417-28
82. Kim KAH, Chakraborti T, Goldstein G, Bressler J. 1997. Induction of immediate early genes (IERG) by lead. Fund. Appl. Toxicol. 36:66 (Abstr.)
83. Fox DA, Sillman AJ. 1979. Heavy metals affect rod, but not cone, photoreceptors. Science 206:78-80
84. Otto DA, Fox DA. 1993. Auditory and visual dysfunction following lead exposure. NeuroToxicology 14:191-207
85. Fox DA, Srivastava D. 1995. Molecular mechanism of the lead-induced inhibition of rod cGMP phosphodiesterase. Toxicol. Lett. 82-83:263-70
86. 2+-stimulated nitric oxide synthase activity from rat cerebellum. Neurosci. Lett. 196:65-68
87. Blazka ME, Harry GJ, Luster MI. 1994. Effect of lead acetate on nitrite production by murine brain endothelial cell cultures. Toxicol. Appl. Pharmacol. 126:191-94
88. Kala SV, Hawkins DH, Jodhav AL. 1996. Low-level subchronic exposure to lead does not affect nitric oxide synthase activity in rat frontal cortex. Toxic Subst. Mech. 15:333-41
89. Hoek JB, Rubin E. 1990. Alcohol and membrane-associated signal transduction. Alcohol Alcohol. 25:143-56
90. Hoffman PL, Tabakoff B. 1990. Ethanol and guanine nucleotide binding proteins: selective interaction. FASEB J. 4:2612-22
91. Gordon AS, Collier K, Diamond I. 1986. Ethanol regulation of adenosine receptor-stimulated cAMP levels in a clonal neural cell line: an in vitro model of cellular tolerance to ethanol. Proc. Natl. Acad. Sci. USA 83:2105-8
92. Saito T, Lee JM, Hoffman PL, Tabakoff B. 1987. Effects of chronic ethanol treatment on the β-adrenergic receptor-coupled adenylate cyclase system of mouse cerebral cortex. J. Neurochem. 48:1817-22
93. Mochly-Rosen D, Chang FH, Cheever L, Kim M, Diamond I, Gordon AS. 1988. Chronic ethanol causes heterologous desensitization of receptors by reducing as messenger RNA. Nature 333:848-50
94. Hatta S, Saito T, Ohshika H. 1994. Effects of ethanol on the function of G proteins in rat cerebral cortex membranes. Alcohol Alcohol. 29:45-51
95. Hoek JB, Thomas AP, Rooney TA, Higashi K, Rubin E. 1992. Ethanol and signal transduction in the liver. FASEB J. 6:2386-96
96. Larsson C, Simonsson P, Hoek JB, Ailing C. 1995. Ethanol inhibits the peak of muscarinic receptor stimulated formation of inositol 1,4,5-trisphosphate in neuroblastoma SH-SY5Y cells. Biochem. Pharmacol. 50:647-54
97. Chang ZL, Puhl HL, May LG, Williams CL, Aronstam RS. 1997. Influence of acute and chronic ethanol treatment on muscarinic responses and receptor expression in CHO cells. Biochem. Pharmacol. In press
98. Gustavsson L, Ailing C. 1987. Formation of phosphatidylethanol in rat brain by phospholipase D. Biochem. Biophys. Res. Commun. 142:958-63
99. Asaoka Y, Kikkawa U, Sekiguchi K, Shearman MS, Kosawa Y, et al. 1988. Activation of brain-specific protein kinase C subspecies in the presence of phosphatidylethanol. FEBS Lett. 231: 221-24
100. Battaini F, Del Vesco R, Govoni S, Trabucchi M. 1989. Chronic alcohol intake modifies phorbol ester binding in selected rat brain areas. Alcohol 6:169-72
101. Kruger H, Wilce PA, Shanley BC. 1993. Ethanol and protein kinase C in rat brain. Neurochem. Int. 22:575-81
102. Virmani M, Ahluwalia B. 1992. Biphasic protein kinase C translocation in PC 12 cells in response to short term and long term ethanol exposure. Alcohol Alcohol. 27:393-401
103. Slater SJ, Cox KJA, Lombardi JV, Ho C, Kelly MB, et al. 1993. Inhibition of protein kinase C by alcohols and anesthetics. Nature 364:82-84
104. Slater SJ, Kelly MB, Larkin JD, Ho C, Mazurek A, et al. 1997. Interaction of alcohols and anethetics with protein kinase Cα. J. Biol Chem. 272:6167-73
105. Smith TL, Bitrick MS. 1996. Ethanol enhances the in situ phosphorylation of MARCKS and protein kinase C activity in primary cultures of astrocytes. Life Sci. 58:855-60
106. Roivanen R, McMahon T, Messing RO. 1993. Protein kinase C isozymes that mediate enhancement of neurite outgrowth by ethanol and phorbol esters in PC12 cells. Brain Res. 624:85-93
107. Sanna E, Dildy-Mayfield JE, Harris RA. 1994. Ethanol inhibits the function of 5-hydroxytryptamine type 1c and muscarinic m1 G protein-linked receptors in Xenopus oocytes expressing brain mRNA: role of protein kinase C. Mol. Pharmacol. 45:1004-12
108. Streissguth AP, Landesman-Dwyer S, Martin JC, Smith DW. 1980.Teratogenic effects of alcohol in humans and laboratory animals. Science 209:353-61
109. Streissguth AP, Aase JM, Clarren SK, Randels SP, La Due RA, Smith DF. 1991. Fetal alcohol syndrome in adolescents and adults. J. Am. Med. Assoc. 265:1961-67
110. Spohr HL, Willms J, Steinhausen HC. 1993. Pre-natal alcohol exposure and long-term developmental consequences. Lancet 341:907-10
111. Smitherman CH. 1994. The lasting impact of fetal alcohol syndrome and fetal alcohol effect on children and adolescents. J. Pediatr. Health Care 8: 121-26
112. Samson HH. 1986. Microcephaly and fetal alcohol syndrome: human and animal studies. See Ref. 182, pp. 167-83
113. West JR, Pierce DR. 1986. Perinatal alcohol exposure and neuronal damage. See Ref. 182, pp. 120-57
114. Ledig M, Tholey G. 1994. Fetal alcohol exposure and glial cell development. In Research Monograph No. 24: Alcohol and Glial Cells, ed. FE Lancaster, pp. 117-30. Bethesda: Natl. Inst. Alcohol Abuse Alcohol.
115. Druse MJ. 1986. Effects of perinatal alcohol exposure on neurotransmitters, membranes and proteins. See Ref. 182, pp. 343-72
116. Balduini W, Murphy SD, Costa LG. 1987. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain. J. Pharmacol. Exp. Ther. 241:421-27
117. Heacock AM, Fisher SK, Agranoff BW. 1987. Enhanced coupling of neonatal muscarinic receptors in rat brain to phosphoinositide turnover. J. Neurochem. 48:1904-11
118. Dobbing H, Sands J. 1979. Comparative aspects of the brain growth spurt. Early Hum. Dev. 3:79-83
119. Costa LG. 1993. Muscarinic receptors and the developing nervous system. In Receptors in the Developing Nervous System, ed. IS Zagon, PJ McLaughlin, pp. 21-42. London: Chapman & Hall
120. Balduini W, Costa LG. 1989. Effects of ethanol on muscarinic receptor-stimulated phosphoinositide metabolism during brain development. J. Pharmacol. Exp. Ther. 250:541-47
121. Reno F, Tan XX, Balduini W, Costa LG. 1994. Administration of ethanol during the rat's brain growth spurt causes dose-dependent microencephaly and inhibition of muscarinic receptor-stimulated phosphoinositide metabolism. Res. Commun. Alcohol Subst. Abuse 15:141-50
122. Balduini W, Candura SM, Manzo L, Cattabeni F, Costa LG. 1991. Time-, concentration-, and age-dependent inhibition of muscarinic receptor-stimulated phosphoinositide metabolism by ethanol in the developing rat brain. Neurochem. Res. 16:1235-40
123. Balduini W, Reno F, Costa LG, Cattabeni F. 1994. Developmental neurotoxicity of ethanol: further evidence for an involvement of muscarinic receptor-stimulated phosphoinositide metabolism. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 266:283-89
124. Balduini W, Costa LG. 1990. Developmental neurotoxicity of ethanol: in vitro inhibition of muscarinic receptor-stimulated phosphoinositide metabolism in rat brain. Brain Res. 512:248-52
125. Candura SM, Manzo L, Costa LG. 1992. Inhibition of muscarinic receptor and G-protein dependent phosphoinositide metabolism in cerebrocortical membranes from neonatal rats by ethanol. NeuroToxicology 13:281-88
126. Kovacs K, Kavanagh TJ, Costa LG. 1995. Ethanol inhibits muscarinic receptor-stimulated phosphoinositide metabolism and calcium mobilization in rat primary cortical cultures. Neurochem. Res. 13:771-76
127. Ashkenazi A, Ramachandran J, Capon DJ. 1989. Acetylcholine analogue stimulates DNA synthesis in brain derived cells via specific muscarinic receptor subtypes. Nature 340:146-50
128. Guizzetti M, Costa P, Peters J, Costa LG. 1996. Acetylcholine as a mitogen: muscarinic receptor-mediated proliferation of rat astrocytes and human neuroblastoma cells. Eur. J. Pharmacol. 297:265-73
129. Guizzetti M, Costa LG. 1996. Inhibition of muscarinic receptor-stimulated glial cell proliferation by ethanol. J. Neurochem. 67:2236-45
130. Kondou H, Inagaki N, Fukui H. 1994. Formation of inositol phosphates mediated by M3 muscarinic receptors in type-1 and type-2 astrocytes from neonatal rat cerebral cortex. Neurosci. Lett. 180:31-134
131. Costa LG, Balduini W, Reno F. 1995. Muscarinic receptor stimulation of phospholipase D activity in the developing brain. Neurosci. Res. Commun. 17:169-76
132. Venance L, Stella N, Glowinski J, Giaume C. 1997. Mechanism involved in initiation and propagation of receptor-induced intercellular calcium signaling in cultured rat astrocytes. J. Neurosci. 17:1981-92
133. Gafni J, Munsch JA, Lam TH, Catlin MC, Costa LG, et al. 1997. Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor calcium pore. Neuron. In press
134. Resnicoff M, Rubini M, Baserga R, Rubin R. 1994. Ethanol inhibits insulin-like growth factor-1 signaling and proliferation of C6 rat glioblastoma cells. Lab. Invest. 71:657-62
135. Hoffman PL, Tabakoff B. 1996. To be or not to be: how ethanol can affect neuronal death during development. Alcohol. Clin. Exp. Res. 20:193-95
136. D'Mello SR, Galli C, Ciotti T, Calissano P. 1993. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor-1 and cAMP. Proc. Natl. Acad. Sci. USA 90:10989-93
137. Galli C, Meucci O, Scorziello A, Werge TM, Calissano P, Schettini G. 1995. Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J. Neurosci. 15:1172-79
138. Copani A, Bruno VMG, Barresi V, Battaglia G, Condorelli DF, Nicoletti F. 1995. Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture. J. Neurochem. 64:101-8
139. Balazs R, Hack N, Jorgensen OS. 1988. Stimulation of the N-methyl-D-aspartate receptor has a trophic effect on differentiating cerebellar granule cells. Neurosci. Lett. 87:80-86
140. Yan G-M, Lin S-Z, Irwin RP, Paul SM. 1995. Activation of muscarinic cholinergic receptors blocks apoptosis of cultured cerebellar granule neurons. Mol. Pharmacol 47:248-57
141. Wegelius K, Korpi ER. 1995. Ethanol inhibits NMDA-induced toxicity and trophism in cultured cerebellar granule cells. Acta Physiol. Scand. 154:25-34
142. Castoldi AF, Li B, Manzo L, Costa LG. 1996. Ethanol inhibits the neuroprotective action of NMDA in cerebellar granule cells. Alcohol Clin. Exp. Res. 20:8A (Abstr.)
143. Bhave SV, Hoffman PL. 1997. Ethanol promotes apoptosis in cerebellar granule cells by inhibiting the trophic effect of NMDA. J. Neurochem. 68:578-86
144. Yan G-M, Lin S-Z, Irwin RP, Paul SM. 1995. Activation of G proteins bidirectionally affects apoptosis of cultured cerebellar granule neurons. J. Neurochem. 65:2425-31
145. D'Mello SR, Borodezt K, Soltoff SP. 1997. Insulin-like growth factor-1 and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of PI 3-kinase in IGF-1 signaling. J. Neurosci. 17:1548-60
146. Itano Y, Ito A, Uehara T, Nomura Y. 1996. Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells: positive and negative effects of protein kinases C and A, respectively. J. Neurochem. 67:131-37
147. Taylor J, Gatchalian CL, Keen G, Rubin LL. 1997. Apoptosis in cerebellar granule neurones: involvement of interleukin-1 beta converting enzyme-like proteases. J. Neurochem. 68:1598-605
148. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-31
149. Takadera T, Suzuki R, Mohri T. 1990. Protection by ethanol of cortical neurons from N-methyl-D-aspartate-induced neurotoxicity is associated with blocking calcium influx. Brain Res. 537:109-14
150. Snell LD, Tabakoff B, Hoffman PL. 1994. Involvement of protein kinase C in ethanol-induced inhibition of NMDA receptor function in cerebellar granule cells. Alcohol Clin. Exp. Res. 18:81-85
151. Sluvkin II, and Jerrells TR. 1995. Different pathways of in vitro ethanol-induced apoptosis in thymocytes and splenic T and B lymphocytes. Immunopharmacology 31:43-57
152. Kurose I, Higuchi H, Miura S, Saito H, Watabnabe N, et al. 1997. Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology 25:368-78
153. Cartwright MM, Smith SM. 1995. Increased cell death and reduced neural crest cell numbers in ethanol-exposed embryos: partial basis for the fetal alcohol syndrome phenotype. Alcohol Clin. Exp. Res. 19:378-86
154. Zimmerman BT, Crawford GD, Dahl R, Simon FR, Mapoles JE. 1995. Mechanisms of acetaldehyde-mediated growth inhibition: delayed cell cycle progression and induction of apoptosis. Alcohol Clin. Exp. Res. 19:434-40
155. De A, Boyadjieva NI, Pastorcic M, Reddy BV, Sarkar DK. 1994. Cyclic AMP and ethanol interact to control apoptosis and differentiation in hypothalamic beta-endorphin neurons. J. Biol. Chem. 269:26697-705
156. 155a. Cheema ZF, West JR, Miranda RC. 1997. Ethanol induction of apoptosis correlates with the induction of the cytotoxic receptor Fas/Apo [Apoptosis]-1 in explants of the developing cerebral cortex. Alcohol Clin. Exp. Res. 21:48A (Abstr.) (Suppl.)
157. Jacobson JL, Jacobson SW, Humphrey HEB. 1990. Effects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children. J. Pediatr. 116:38-45
158. Rogan WJ, Gladen BC. 1992. Neurotoxicology of PCBs and related compounds. NeuroToxicology 13:27-36
159. Chen Y-CJ, Guo Y-L, Hsu C-C, Rogan WJ. 1992. Cognitive development of Yu-Cheng (oil disease) children prenatally exposed to heat-degraded PCBs. J. Am Med. Assoc. 268:3213-18
160. Seegal RF. 1996. Epidemiological and laboratory evidence of PCB-induced neurotoxicity. Crit. Rev. Toxicol. 26: 709-37
161. Kodavanti PRS, Shin D, Tilson HA, Harry GJ. 1993. Comparative effects of two polychlorinated biphenyl congeners on calcium homeostasis in rat cerebellar granule cells. Toxicol. Appl. Pharmacol. 123:97-106
162. Kodavanti PRS, Shafer TJ, Ward TR, Mundy WR, Freudenrich T, et al. 1994. Differential effects of polychlorinated biphenyl congeners on phosphoinositide hydrolysis and protein kinase C translocation in rat cerebellar granule cells. Brain Res. 662:75-82
163. Kodavanti PRS, Ward TR, McKinney JD, Tilson HA. 1995. Increased 3H-phorbol ester binding in rat cerebellar granule cells by polychlorinated biphenyl mixtures and congeners: structure-activity relationships. Toxicol. Appl. Pharmacol. 130:140-48
164. 2+ homeostasis. Toxicol. Appl. Pharmacol. 141:448-55
165. Evans CJ, Karpel S. 1985. Organotin Compounds in Modern Technology. Amsterdam: Elsevier. 279 pp.
166. Walsh TJ, DeHaven DL. 1988. Neurotoxicity of the alkyltins. In Metal Neurotoxicity, ed. SC Bondy, KN Presad, pp. 87-108. Boca Raton, FL: CRC
167. Besser R, Kramer G, Thumler R, Bohl J, Gutmann L, Hopf HC. 1987. Acute trimethyltin limbic cerebellar syndrome. Neurology 37:945-50
168. Chang LW. 1986. Neuropathology of trimethyltin: a proposed pathogenetic mechanism. Fund. Appl. Toxicol. 6:217-32
169. Krady JK, Oyler GA, Balaban CD, Billingsley ML. 1990. Use of avidinbiotin subtractive hybridization to characterize mRNA common to neurons destroyed by the selective neurotoxicant trimethyltin. Mol. Brain Res. 77:287-97
170. Toggas SM, Krady JK, Billingsley ML. 1992. Molecular neurotoxicology of trimethyltin: identification of stannin, a novel protein expressed in trimethyltin-sensitive cells. Mol. Pharmacol. 42:44-56
171. Thompson TA, Lewis JM, Dejneka NS, Severs WB, Polavarapu R, Billingsley ML. 1996. Induction of apoptosis by organotin compounds in vitro: neuronal protection with antisense oligonucleotides directed against stannin. J. Pharmacol. Exp. Ther. 276:1201-15
172. 2+ by neurotoxic organometals: distinctive mechanisms. Toxicol. Appl. Pharmacol. 88:77-86
173. Fechter LD, Liu Y. 1995. Elevation of intracellular calcium levels in spiral ganglion cells by trimethyltin. Hear. Res. 91:101-9
174. Pavlakovic G, Kane MD, Eyer CL, Kanthasamy A, Isom GE. 1995, Activation of protein kinase C by trimethyltin: relevance to neurotoxicity. J. Neurochem. 65:2338-43
175. Liu Y, Fechter LD. 1996. Comparison of the effects of trimethyltin on the intracellular calcium levels in spiral ganglion cells and outer hair cells. Acta Otolaryngol. Stockh. 116:417-21
176. 2+ concentration in rat cerebellar neurons. Eur. J. Pharmacol. 248:89-93
177. Viviani B, Marinovich M, Galli CL. 1996. Apoptosis as a mechanism of trimethyltin induced cell death in a human neuroblastoma cell line. Fund. Appl. Toxicol. 30:229 (Abstr.)
178. Aschner M, Aschner JL. 1992. Cellular and molecular effects of trimethyltin and triethyltin: relevance to organotin neurotoxicity. Neurosci. Biobehav. Rev. 16:427-35
179. Lucas M, Sanchez-Margalet V. 1995. Protein kinase C involvement in apoptosis. Gen. Pharmacol. 5:881-87
180. Mattson MP. 1991. Evidence for the involvement of protein kinase C in neurodegenerative changes in culture human cortical neurons. Exp. Neurol. 112:95-103
181. Mailhos C, Howard MK, Lachtman DS. 1994. A common pathway mediates retinoic acid and PMA-dependent programmed cell death (apoptosis) of neuronal cells. Brain Res. 644:7-12
182. Bertrand R, Solary E, O'Connor P, Kohn KW, Pommier Y. 1994. Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res. 211:314-21
183. West JR, ed. 1986. Alcohol and Brain Development. Oxford: Oxford Univ. Press